These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 36373804)

  • 1. Disparities in substance use treatment retention: An exploration of reasons for discharge from publicly funded treatment.
    Borton D; Streisel S; Stenger M; Fraser K; Sutton M; Wang YC
    J Ethn Subst Abuse; 2022 Nov; ():1-19. PubMed ID: 36373804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disparities in Criminal Justice Outcomes After Beginning Treatment for Substance Use Disorders: The Influence of Race/Ethnicity and Place.
    Acevedo A; Miles J; Panas L; Ritter G; Campbell K; Garnick D
    J Stud Alcohol Drugs; 2019 Mar; 80(2):220-229. PubMed ID: 31014467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disparities in completion of substance abuse treatment between and within racial and ethnic groups.
    Guerrero EG; Marsh JC; Duan L; Oh C; Perron B; Lee B
    Health Serv Res; 2013 Aug; 48(4):1450-67. PubMed ID: 23350871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Demographics of the Population Experiencing Homelessness and Receiving Publicly Funded Substance Use and Mental Health Treatment Services in Delaware.
    Borton D; Ryding R; Scales MJ; Fraser K
    Dela J Public Health; 2023 Jun; 9(2):14-17. PubMed ID: 37622147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comprehensive analysis of discharge reasons from methadone outpatient treatment programs.
    Andraka-Christou B; Totaram R; Nguyen TD
    Am J Addict; 2022 Nov; 31(6):508-516. PubMed ID: 35996855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Residential and outpatient treatment completion for substance use disorders in the U.S.: Moderation analysis by demographics and drug of choice.
    Stahler GJ; Mennis J; DuCette JP
    Addict Behav; 2016 Jul; 58():129-35. PubMed ID: 26925821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Employment after beginning treatment for substance use disorders: The impact of race/ethnicity and client community of residence.
    Acevedo A; Miles J; Garnick DW; Panas L; Ritter G; Campbell K; Acevedo-Garcia D
    J Subst Abuse Treat; 2018 Apr; 87():31-41. PubMed ID: 29471924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Substance abuse treatment in correctional versus non-correctional settings: Analysis of racial/ethnic and gender differences.
    Pro G; Camplain R; Sabo S; Baldwin J; Gilbert PA
    J Health Dispar Res Pract; 2019; 12(3):1-20. PubMed ID: 33110710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Perceptions of White Clients in a Substance Abuse Program in Which They Are in the Minority.
    Senreich E
    Subst Use Misuse; 2017 Jan; 52(1):34-38. PubMed ID: 27680287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Substance use improvement depends on Race/Ethnicity: Outpatient treatment disparities observed in a large US national sample.
    Sahker E; Pro G; Sakata M; Furukawa TA
    Drug Alcohol Depend; 2020 Aug; 213():108087. PubMed ID: 32492601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A multilevel decomposition approach to estimate the role of program location and neighborhood disadvantage in racial disparities in alcohol treatment completion.
    Jacobson JO; Robinson P; Bluthenthal RN
    Soc Sci Med; 2007 Jan; 64(2):462-76. PubMed ID: 17055634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How the states stack up: disparities in substance abuse outpatient treatment completion rates for minorities.
    Arndt S; Acion L; White K
    Drug Alcohol Depend; 2013 Oct; 132(3):547-54. PubMed ID: 23664124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors supporting substance use improvement for Black Americans: A population health observational study.
    Sahker E; Pro G; Sakata M; Poudyal H; Jordan A; Furukawa TA
    Drug Alcohol Depend; 2022 May; 234():109405. PubMed ID: 35316688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Homelessness and publicly funded substance use disorder treatment in California, 2016-2019: Analysis of treatment needs, level of care placement, and outcomes.
    Padwa H; Bass B; Urada D
    J Subst Abuse Treat; 2022 Jun; 137():108711. PubMed ID: 35012791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Completion rates of clients discharged from drug and alcohol treatment programs in Washington State.
    Wickizer T; Maynard C; Atherly A; Frederick M; Koepsell T; Krupski A; Stark K
    Am J Public Health; 1994 Feb; 84(2):215-21. PubMed ID: 8296943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Race, ethnicity, and emergency department post-overdose care.
    Reddy NG; Jacka B; Ziobrowski HN; Wilson T; Lawrence A; Beaudoin FL; Samuels EA
    J Subst Abuse Treat; 2021 Dec; 131():108588. PubMed ID: 34384652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Using the DATCAP and ASI to estimate the costs and benefits of residential addiction treatment in the State of Washington.
    French MT; Salomé HJ; Carney M
    Soc Sci Med; 2002 Dec; 55(12):2267-82. PubMed ID: 12409139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Racial Disparities in Payment Source of Opioid Use Disorder Treatment among Non-Incarcerated Justice-Involved Adults in the United States.
    Sanmartin MX; McKenna RM; Ali MM; Krebs JD
    J Ment Health Policy Econ; 2020 Mar; 23(1):19-25. PubMed ID: 32458814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gender disparities in access and retention in outpatient methadone treatment for opioid use disorder in low-income urban communities.
    Marsh JC; Amaro H; Kong Y; Khachikian T; Guerrero E
    J Subst Abuse Treat; 2021 Aug; 127():108399. PubMed ID: 34134873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.